跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Llanol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Llanol
Approved
STANDARD
Llanol
Amherst laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bb5166a21a318158
Company
Amherst laboratories, Inc.
Type
Standard
Approval Details
Approval Id
bb5166a21a318158
Drug Approval Philippines Name
Llanol
Product Name
Llanol
Registration Number
DR-7571
Brand Name
Llanol
Generic Name
Allopurinol
Dosage Form
Tablet
Dosage Strength
100 mg
Manufacturer
Amherst laboratories, Inc.
Trader
UNILAB, Inc.
Issuance Date
26 May 2022
Expiry Date
30 May 2027
Pharmacologic Category
Antigout
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bb5166a21a318158
Type
Standard
Back to Philippines FDA Approvals